Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
for Ig-E Mediated Food Allergy
Drug: RPT904
Sites in Minneapolis +21 more locations
Sponsor: RAPT Therapeutics, Inc.
Sex: All·Age: 12 - 55
Code: NCT07220811·Phase 2·Recruiting·Listed Oct 2025